Skip to content

A research study to evaluate the effects of single doses of NNC0614-0001 in healthy adult volunteers, and participants with hereditary haemochromatosis type 1.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504574-38-00
Acronym
NN7614-7656
Enrollment
66
Registered
2024-07-29
Start date
2024-09-06
Completion date
Unknown
Last updated
2025-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary haemochromatosis (HH) type 1

Interventions

None listed

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Austria

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026